LRRC25 anticorps (C-Term)
Aperçu rapide pour LRRC25 anticorps (C-Term) (ABIN953214)
Antigène
Voir toutes LRRC25 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 249-278, C-Term
-
Specificité
- This antibody recognizes Human LRRC25 (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 249-278 amino acids from the C-terminal region of human LRRC25
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LRRC25 (Leucine Rich Repeat Containing 25 (LRRC25))
-
Autre désignation
- LRRC25
-
Sujet
- May be involved in the activation of cells of innate and acquired immunity.Synonyms: Leucine-rich repeat-containing protein 25, MAPA, Monocyte and plasmacytoid-activated protein
-
Poids moléculaire
- 33179 Da
-
ID gène
- 126364
-
NCBI Accession
- NP_660299
Antigène
-